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Background: Waitlist mortality for children remains high. Potential donor hearts with depressed ventricular function are often declined. The 
purpose of our study was to assess if pediatric heart transplant (HT) recipients of grafts with depressed left ventricular ejection fraction (LVEF) would 
have comparable survival to those with normal LVEF.
Methods: Retrospective study of the United Network of Organ Sharing Database for pediatric HTs from 10/26/1999 to 06/30/2011. Patients 
(pts) were grouped based on donor LVEF: normal (LVEF ≥ 55%), mildly depressed (LVEF 45-54%), or moderate to severely depressed (LVEF < 45). The 
primary outcome was graft survival.
Results: During the study period there were 3,672 pediatric HTs; 3,306 (90%) had a LVEF reported. LVEF was mildly depressed in 245 (7%) 
and moderately to severely depressed in 172 (5%). Pts receiving grafts with moderately to severely depressed LVEF were younger and weighed 
less (p<0.001 for both) than those receiving grafts with higher LVEF. Donors with depressed LVEF were more likely to be on inotropes (p=0.04), 
but the recipient use of inotropes (p=0.94), mechanical ventilation (p=0.49), and extracorporeal membrane oxygenation (p=0.41) did not differ 
between LVEF groups. Thirty day, 6 month, 1 and 5 year (yr) graft survival was similar among donor LVEF groups. Median graft survival from donors 
with normal LVEF (10.6 yrs) was similar to survival from donors with mildly depressed LVEF (9.7 yrs, p=0.24), and from donors with moderately to 
severely depressed LVEF (9.1 yrs, p=0.13). On multivariable analysis, moderately to severely depressed LVEF (HR 1.18, 95% CI 0.91-1.54) and mildly 
depressed LVEF (HR 1.23, 95% CI 0.97-1.57) had similar survival compared to normal LVEF.
Conclusions: Use of donors with depressed LVEF is uncommon in pediatric HTs (<15%), yet graft survival does not significantly differ from donors 
with normal LVEF. Hearts from donors with depressed LVEF should be considered in selected pediatric HT pts.
